UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
FDA approves treatment for rare blood cancer
The U.S. Food and Drug Administration Monday granted accelerated approval f...
by Constance Williams
|
2017-11-07 11:28
라인
Drugmaker, regulators urged to end price talks for lung cancer therapy
A group of cancer patients and their families called for AstraZeneca Korea한...
by Constance Williams
|
2017-11-06 17:59
라인
Seoul Pharma signs $7.07-million export contract with Saudi partner
Seoul Pharmaceuticals said Monday that it has signed a contract with SAJA P...
by Constance Williams
|
2017-11-06 15:48
라인
Daewoong prepares to enter US market with botulinum toxin
Daewoong Pharmaceuticals said Monday the company has registered its botulin...
by Constance Williams
|
2017-11-06 13:29
라인
GSK’s pulmonary hypertension drug gains extended coverage
The Ministry of Health and Welfare Wednesday provided an additional coverag...
by Marian Chu
|
2017-11-06 13:19
라인
Students misusing ADHD medication risks increase in suicidal thoughts
Every November, the entire nation holds its breath as they watch senior hig...
by Constance Williams
|
2017-11-03 17:37
라인
Pharmacists slam financing of blockbuster 'dementia medicine'
Korean pharmacists Friday accused the government of turning a blind eye to ...
by Marian Chu
|
2017-11-03 16:05
라인
CJ Healthcare put up for sale
CJ Healthcare will be put up for sales.Kang Seok-hee 강석희, CJ Healthcare CJ헬...
by Lee Han-soo
|
2017-11-03 15:11
라인
FDA gives ‘breakthrough’ status to GSK’s blood cancer drug
The U.S. Food and Drug Administration has granted breakthrough therapy stat...
by Marian Chu
|
2017-11-03 11:25
라인
LG Household & Healthcare acquires Taiguk Pharma
LG Household & Healthcare (H&H) said Thursday that it has signed an agreeme...
by Lee Han-soo
|
2017-11-02 17:40
라인
Allergan nixes contract with Dong-A ST over evogliptin license
Allergan has nullified its contract with Dong-A ST over the exclusive right...
by Lee Hye-seon
|
2017-11-02 13:59
라인
Patient-centric clinical development essential
The 2017 KoNECT-DIA International Conference on Clinical Trials opened its ...
by Lee Han-soo
|
2017-11-01 17:23
라인
Drugmakers see robust earnings in Q3
Yuhan Corp. and Green Cross, Korea’s two largest pharmaceutical firms by sa...
by Lee Hye-seon
|
2017-11-01 13:19
라인
FDA approves AstraZeneca's treatment for rare blood cancer
The U.S. Food and Drug Administration Wednesday granted accelerated approva...
by Marian Chu
|
2017-11-01 10:35
라인
Novo Nordisk Korea’s Tresiba 1st in next-generation insulin market
Novo Nordisk Korea announced Tuesday that its ultralong-acting basal insuli...
by Constance Williams
|
2017-10-31 16:53
라인
Drugmakers brace for possible renegotiation of Korea-US FTA
Korean drugmakers and biopharma manufacturers are bracing for possible chan...
by Lee Hye-seon
|
2017-10-31 16:38
라인
Green Cross opens factory in Canada
Green Cross Biotherapeutics Factory in Canada Green Cross Biotherapeutics...
by Lee Han-soo
|
2017-10-31 16:28
라인
AbbVie Korea applies for insurance coverage of non-infectious uveitis treatment
AbbVie Korea said Tuesday that its non-infectious uveitis treatment Humira ...
by Constance Williams
|
2017-10-31 15:58
라인
‘How will Amazon’s entry into healthcare business affect Korea?’
Fears of Amazon entering the U.S. healthcare industry have already crossed ...
by Marian Chu
|
2017-10-31 11:53
라인
Korea strives to develop vaccines to reduce dependency on import
Government and business officials are trying hard to make Korea an independ...
by Lee Han-soo
|
2017-10-31 06:00
-
이전
101
102
103
104
105
106
107
108
109
110
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top